{"log_id": 1890812527116690101, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0.047835, "average": 0.838397, "min": 0.199404}, "location": {"width": 1264, "top": 182, "height": 36, "left": 242}, "words": "和重度(Ci Puel (,n=6肝与能受损患当的依维暴量(即AUC分别上升了1.8、3.2和3.6倍"}, {"probability": {"variance": 0.019425, "average": 0.91491, "min": 0.403564}, "location": {"width": 1291, "top": 235, "height": 43, "left": 240}, "words": "在另一项究中发现,8名中度功能受损( Child Pugh B级)受试者其依维莫司平均AUIC是8名肝功能正"}, {"probability": {"variance": 0.011843, "average": 0.920203, "min": 0.704726}, "location": {"width": 189, "top": 290, "height": 34, "left": 240}, "words": "受试者的2倍"}, {"probability": {"variance": 0.010436, "average": 0.945592, "min": 0.45512}, "location": {"width": 1241, "top": 345, "height": 43, "left": 290}, "words": "对于重度肝功能受损的晚期肾细胞患者,如果预期利益超过风险,可以减量使用本品。对于轻度或中"}, {"probability": {"variance": 0.011097, "average": 0.949744, "min": 0.606635}, "location": {"width": 678, "top": 402, "height": 34, "left": 235}, "words": "度肝功能受损患考,建降低剂(参见【法量】"}, {"probability": {"variance": 0.022594, "average": 0.911722, "min": 0.384922}, "location": {"width": 1243, "top": 454, "height": 41, "left": 290}, "words": "对干轻度或中度所功能受损的管膜下巨细胞尾形细胞患者,应基十治疗药物监测来谐整本品的量"}, {"probability": {"variance": 0.036842, "average": 0.888194, "min": 0.361341}, "location": {"width": 1296, "top": 507, "height": 45, "left": 237}, "words": "对于度功能受损的定膜下一细胞星形胞瘤患者,本品的起始剂降低大约S0%,后续的剂调"}, {"probability": {"variance": 0.035659, "average": 0.860406, "min": 0.409571}, "location": {"width": 907, "top": 564, "height": 36, "left": 237}, "words": "整于治疗药物监见【用法用量】“治疗药物监测”和“剂量调整"}, {"probability": {"variance": 0.001974, "average": 0.966833, "min": 0.884518}, "location": {"width": 219, "top": 619, "height": 32, "left": 235}, "words": "年龄和性别的影响"}, {"probability": {"variance": 0.024796, "average": 0.882936, "min": 0.464407}, "location": {"width": 1040, "top": 672, "height": 41, "left": 290}, "words": "症患者体药代动力学浮估显示:表观清除率与患者年龄或性别之间没有明显关系"}, {"probability": {"variance": 0.036926, "average": 0.876705, "min": 0.358677}, "location": {"width": 1245, "top": 729, "height": 36, "left": 290}, "words": "在管下细胞形细胞瘤忠中,按mg/m2剂标准化后的几何平均Cn值在<10岁和10至<18"}, {"probability": {"variance": 0.023111, "average": 0.907022, "min": 0.368949}, "location": {"width": 1298, "top": 781, "height": 38, "left": 235}, "words": "岁思老分别比成人患老(>18岁)54%和40%,表明按体表面积示准化后的依维莫司除率的对比结果为"}, {"probability": {"variance": 0.0197, "average": 0.897632, "min": 0.601229}, "location": {"width": 276, "top": 836, "height": 36, "left": 233}, "words": "儿童患者高于成人患者"}, {"probability": {"variance": 0.011627, "average": 0.840593, "min": 0.732765}, "location": {"width": 57, "top": 893, "height": 34, "left": 233}, "words": "种族"}, {"probability": {"variance": 0.01745, "average": 0.899639, "min": 0.547172}, "location": {"width": 1008, "top": 946, "height": 41, "left": 285}, "words": "根据变义研究对比,在应相同剂量时日本患者(n=6)的平均暴露高干非日本患者"}, {"probability": {"variance": 0.023896, "average": 0.904144, "min": 0.433972}, "location": {"width": 912, "top": 1001, "height": 36, "left": 285}, "words": "根据群体药代动力学分析,黑人口1服清除率(CF)白人平均高"}, {"probability": {"variance": 0.034091, "average": 0.856869, "min": 0.395697}, "location": {"width": 854, "top": 1056, "height": 36, "left": 288}, "words": "尚未确定日本或黑人怎者中这差异对依维莫安全性和有效性的意义"}, {"probability": {"variance": 0.017397, "average": 0.911004, "min": 0.590536}, "location": {"width": 226, "top": 1110, "height": 32, "left": 233}, "words": "暴露量与效应关系"}, {"probability": {"variance": 0.025576, "average": 0.906625, "min": 0.359606}, "location": {"width": 1243, "top": 1165, "height": 38, "left": 285}, "words": "本品510mg每日一次给药后,肿瘤组织中4E8P1(P4E-BF1)的酸化下降与血液中依维莫司"}, {"probability": {"variance": 0.031015, "average": 0.885755, "min": 0.408305}, "location": {"width": 1298, "top": 1220, "height": 36, "left": 230}, "words": "态平均Cm之间中度关:更多数据表56激酶的磷酸抑制作用对浓莫司抑制mTOR非常敏感。每"}, {"probability": {"variance": 0.039747, "average": 0.835411, "min": 0.360877}, "location": {"width": 818, "top": 1277, "height": 36, "left": 233}, "words": "日10mg剂药后的所有C值均显示完全邦制elFG磷变化"}, {"probability": {"variance": 0.016485, "average": 0.946034, "min": 0.546191}, "location": {"width": 308, "top": 1330, "height": 38, "left": 233}, "words": "中国人群药代动力学致据"}, {"probability": {"variance": 0.023499, "average": 0.89399, "min": 0.436198}, "location": {"width": 1211, "top": 1385, "height": 36, "left": 313}, "words": "项【斯试验证究了中医实体痛息者(n=24)接受依维莫司5mg/日10mg/日药的药代动力学,依维"}, {"probability": {"variance": 0.026878, "average": 0.889492, "min": 0.441915}, "location": {"width": 1289, "top": 1440, "height": 34, "left": 233}, "words": "莫门股给后2~3小时左右达到九药峰浓度.5mg/日10mng/日给药组的平均药物一服清除率(CL/F)分"}, {"probability": {"variance": 0.02305, "average": 0.885314, "min": 0.403404}, "location": {"width": 1264, "top": 1494, "height": 36, "left": 230}, "words": "别为15.8/小时和17.01/小时,中国患者的药物口服清除率与日本瘤思者(5mg日给药组为18.9L/小时"}, {"probability": {"variance": 0.023224, "average": 0.890721, "min": 0.381944}, "location": {"width": 1286, "top": 1549, "height": 36, "left": 237}, "words": "0mg日药组为19.时)和种人种瘤志者(10mg日药为15.4/小时的口服清除率相当。中国"}, {"probability": {"variance": 0.016634, "average": 0.890524, "min": 0.561364}, "location": {"width": 1291, "top": 1604, "height": 36, "left": 230}, "words": "实体瘤患老连续绘予依维莫司后人约在8天达到稳怎浓度。5mg/门和10mg日给药范围内,依维莫可的药"}, {"probability": {"variance": 0.012949, "average": 0.929121, "min": 0.572315}, "location": {"width": 569, "top": 1659, "height": 34, "left": 230}, "words": "代动力学大体呈线关系,稳态时的庄药峰浓度"}, {"probability": {"variance": 6.4e-05, "average": 0.992668, "min": 0.977288}, "location": {"width": 137, "top": 1661, "height": 32, "left": 918}, "words": "血药谷浓度"}, {"probability": {"variance": 0.009939, "average": 0.950715, "min": 0.624205}, "location": {"width": 290, "top": 1659, "height": 32, "left": 1156}, "words": "和药时曲线下面积(AUC"}, {"probability": {"variance": 0.001702, "average": 0.957864, "min": 0.877748}, "location": {"width": 219, "top": 1716, "height": 29, "left": 235}, "words": "与剂量呈比例增加"}, {"probability": {"variance": 0, "average": 0.951779, "min": 0.951779}, "location": {"width": 96, "top": 1824, "height": 32, "left": 217}, "words": "藏"}, {"probability": {"variance": 0.052733, "average": 0.803574, "min": 0.399863}, "location": {"width": 331, "top": 1879, "height": 34, "left": 230}, "words": "30℃以下贮。避光,"}, {"probability": {"variance": 0.051506, "average": 0.843445, "min": 0.401207}, "location": {"width": 164, "top": 1936, "height": 34, "left": 226}, "words": "避儿误取"}, {"probability": {"variance": 0.005539, "average": 0.946754, "min": 0.8415}, "location": {"width": 100, "top": 2039, "height": 32, "left": 212}, "words": "包装〗"}, {"probability": {"variance": 0.029696, "average": 0.791735, "min": 0.386643}, "location": {"width": 441, "top": 2093, "height": 34, "left": 221}, "words": " PAIAL PVC铝泡罩包装。30片/"}], "language": 3}